Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli

International Journal of Antimicrobial Agents

Volumn 48, Issue 3, 2016, Pages 265-270

  Kumar, Manesh ^a   Dhaka, Pankaj ^a   Vijay, Deepthi ^a   Vergis, Jess ^a   Mohan, Vysakh ^a   Kumar, Ashok ^a   Kurkure, Nitin V ^b   Barbuddhe, Sukhadeo B ^c   Malik, S V S ^a   Rawool, Deepak B ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b NAGPUR VETERINARY COLLEGE   (India)

^c ICAR National Institute of Biotic Stress Management   (India)

Author keywords

Drug resistance; Enteroaggregative Escherichia coli; Lactobacillus acidophilus; Lactobacillus plantarum; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL SHEDDING; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTIBIOSIS; BACTERIAL LOAD; ESCHERICHIA COLI INFECTIONS; MALE; MICROBIOLOGY; NEWBORN; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TIME FACTOR; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; ANTIBIOSIS; BACTERIAL LOAD; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; MALE; MICE; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84978879689     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.05.014     Document Type: Article

References (32)

1. [1] Jensen, B.H., Olsen, K.E.P., Struve, C., Krogfelt, K.A., Petersen, A.M., Epidemiology and clinical manifestations of enteroaggregative Escherichia coli. Clin Microbiol Rev 27 (2014), 614–630.
2. [2] Ali, M.M.M., Ahmed, S.F., Klena, J.D., Mohamed, Z.K., Moussa, T.A.A., Ghenghesh, K.S., Enteroaggregative Escherichia coli in diarrheic children in Egypt: molecular characterization and antimicrobial susceptibility. J Infect Dev Ctries 8 (2014), 589–596.
3. [3] Cennimo, D.J., Koo, H., Mohamed, J.A., Huang, D.B., Chiang, T., Enteroaggregative Escherichia coli: a review of trends, diagnosis, and treatment. Infect Med 24 (2007), 100–110.
4. [4] Aslani, M.M., Alikhani, M.Y., Zavari, A., Yousefi, R., Zamani, A.R., Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis 15 (2011), e136–9.
5. [5] Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A.K.M., Wertheim, H.F.L., Sumpradit, N., et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis 13 (2013), 12–20.
6. [6] Khalid, K., An overview of lactic acid bacteria. Int J Biosci 3 (2011), 1–13.
7. [7] Ducrotte, P., Sawant, P., Jayanthi, V., Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol 18 (2012), 4012–4018.
8. [8] McFarland, V.L., Probiotics for the primary and secondary prevention of C. difficile infections: a meta-analysis and systematic review. Antibiotics (Basel) 4 (2015), 160–178.
9. [9] Aggarwal, S., Upadhyay, A., Shah, D., Teotia, N., Agarwal, A., Jaiswal, V., Lactobacillus GG for treatment of acute childhood diarrhoea: an open labelled, randomized controlled trial. Indian J Med Res 139 (2014), 379–385.
10. [10] Mirnejad, R., Vahdati, A.R., Rashidiani, J., Erfani, M., Piranfar, V., The antimicrobial effect of Lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro. Iran Red Crescent Med J 15 (2013), 122–126.
11. [11] Vijay, D., Dhaka, P., Vergis, J., Negi, M., Mohan, V., Kumar, M., et al. Characterization and biofilm forming ability of diarrhoeagenic enteroaggregative Escherichia coli isolates recovered from human infants and young animals. Comp Immunol Microbiol Infect Dis 38 (2015), 21–31.
12. [12] Cravioto, A., Gross, R.J., Scotland, S.M., Rowe, B., An adhesive factor found in strains of Escherichia coli belonging to the traditional infantile enteropathogenic serotypes. Curr Microbiol 3 (1979), 95–99.
13. [13] Bauer, A.W., Kirby, W.M., Sherris, J.C., Turck, M., Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45 (1966), 493–496.
14. [14] Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. 2013, CLSI, Wayne, PA Document M100-S23.
15. [15] Miles, A.A., Misra, S.S., The estimation of the bactericidal power of the blood. J Hyg (Lond), 38, 1938, 732.
16. [16] Bolick, D.T., Roche, J.K., Hontecillas, R., Bassaganya-Riera, J., Nataro, J.P., Guerrant, R.L., Enteroaggregative Escherichia coli strain in a novel weaned mouse model: exacerbation by malnutrition, biofilm as a virulence factor and treatment by nitazoxanide. J Med Microbiol 62 (2013), 896–905.
17. [17] Raju, B., Ballal, M., Multidrug resistant enteroaggregative Escherichia coli diarrhoea in rural southern Indian population. Scand J Infect Dis 41 (2009), 105–108.
18. [18] Shanahan, F., Probiotics in inflammatory bowel disease—therapeutic rationale and role. Adv Drug Deliv Rev 56 (2004), 809–818.
19. [19] Anas, M., Ahmedb, K., Mebroukc, K., Study of the antimicrobial and probiotic effect of Lactobacillus plantarum isolated from raw goat's milk from the region of Western Algeria. Intl Res J Appl Basic Sci 13 (2014), 18–27.
20. [20] Prema, P., In vitro antagonistic activity of a probiotic Lactobacillus plantarum against water borne pathogens. Int J Pharm Pharm Sci 4 (2013), 175–178.
21. [21] Hernandez, D., Cardell, E., Zarate, V., Antimicrobial activity of lactic acid bacteria isolated from Tenerife cheese: initial characterization of plantaricin TF711, a bacteriocin-like substance produced by Lactobacillus plantarum TF711. J Appl Microbiol 99 (2005), 77–84.
22. [22] Ratsep, M., Naaber, P., Koljalg, S., Smidt, I., Shkut, E., Effect of Lactobacillus plantarum strains on clinical isolates of Clostridium difficile in vitro. J Probiotics Health, 2, 2014, 119.
23. [23] Yasin, R.M., Jegathesan, M.M., Tiew, C.C., Salmonella serotypes isolated in Malaysia over the ten-year period 1983–1992. Asia Pac J Public Health 9 (1996), 1–5.
24. [24] Philipson, C.W., Bassaganya-Riera, J., Hontecillas, R., Animal models of enteroaggregative Escherichia coli infection. Gut Microbes 4 (2013), 281–291.
25. [25] Tzipori, S., Montanaro, J., Robins-Browne, R.M., Vial, P., Gibson, R., Levine, M.M., Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model. Infect Immun 60 (1992), 5302–5306.
26. [26] Roche, J.K., Cabel, A., Sevilleja, J., Nataro, J., Guerrant, R.L., Enteroaggregative Escherichia coli (EAEC) impairs growth while malnutrition worsens EAEC infection: a novel murine model of the infection malnutrition cycle. J Infect Dis 202 (2010), 506–514.
27. [27] Saha, D.R., Guin, S., Krishnan, R., Nag, D., Koley, H., Shinoda, S., et al. Inflammatory diarrhea due to enteroaggregative Escherichia coli: evidence from clinical and mice model studies. Gut Pathog, 5, 2013, 36.
28. [28] Ibraheem, S.K., Alshaibani, A.B., Ad'hiah, A.H., Protective effect of Lactobacillus acidophilus and Saccharomyces cerevisiae against multi-drug resistant Salmonella enterica serovar Typhimurium in vitro and in vivo. World J Pharm Res 3 (2014), 193–203.
29. [29] Pretzer, G., Snel, H., Molenaar, D., Wiersman, A., van der Meer, R., Kleerebezem, M., Identification of a mannose-specific adhesin encoding gene in Lactobacillus plantarum. Darmendag, Utrecht, 29 October, 2004.
30. [30] Kopp-Hoolihan, L., Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 101 (2001), 229–241.
31. [31] Neumann, E., Oliveira, M.A.P., Cabral, C.M., Moura, L.N., Nicoli, J.R., Vieira, E.C., et al. Monoassociation with Lactobacillus acidophilus UFV-H2b20 stimulates the immune defense mechanisms of germfree mice. Braz J Med Biol Res 31 (1998), 1565–1573.
32. [32] Kaur, I.P., Chopra, K., Saini, A., Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 15 (2002), 1–9.